These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 1946534)

  • 1. Chemically induced cell proliferation in liver carcinogenesis.
    Popp JA; Marsman DS
    Prog Clin Biol Res; 1991; 369():389-95. PubMed ID: 1946534
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cellular biochemistry of the stepwise development of cancer with chemicals: G. H. A. Clowes memorial lecture.
    Farber E
    Cancer Res; 1984 Dec; 44(12 Pt 1):5463-74. PubMed ID: 6388826
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Peroxisome proliferators: potential role of altered hepatocyte growth and differentiation in tumor development.
    Cattley RC; Miller RT; Corton JC
    Prog Clin Biol Res; 1995; 391():295-303. PubMed ID: 8532723
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Prevention of cancer and the dose-effect relationship: the carcinogenic effects of ionizing radiations].
    Tubiana M
    Cancer Radiother; 2009 Jul; 13(4):238-58. PubMed ID: 19539515
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chemically induced cell proliferation and carcinogenesis: differential effect of compensatory cell proliferation and mitogen-induced direct hyperplasia on hepatocarcinogenesis in the rat.
    Columbano A; Ledda-Columbano GM; Coni P; Pichiri-Coni G; Curto M; Pani P
    Prog Clin Biol Res; 1991; 369():217-25. PubMed ID: 1946520
    [No Abstract]   [Full Text] [Related]  

  • 6. The role of somatic mutations and cell replication kinetics in quantitative cancer risk assessment.
    Moolgavkar SH; Luebeck EG
    Prog Clin Biol Res; 1991; 369():469-79. PubMed ID: 1835095
    [No Abstract]   [Full Text] [Related]  

  • 7. Liver carcinogenesis is not a predicted outcome of chemically induced hepatocyte proliferation.
    Melnick RL; Huff J
    Toxicol Ind Health; 1993; 9(3):415-38. PubMed ID: 8367884
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chemicals, cell proliferation, risk estimation, and multistage carcinogenesis.
    Pitot HC; Dragan YP; Neveu MJ; Rizvi TA; Hully JR; Campbell HA
    Prog Clin Biol Res; 1991; 369():517-32. PubMed ID: 1946543
    [No Abstract]   [Full Text] [Related]  

  • 9. Mitogenesis and programmed cell death as determinants of carcinogenicity of nongenotoxic compounds.
    Schulte-Hermann R; Bursch W; Parzefall W
    Prog Clin Biol Res; 1991; 369():237-44. PubMed ID: 1946522
    [No Abstract]   [Full Text] [Related]  

  • 10. DNA synthesis, apoptosis, and phenotypic expression as determinants of growth of altered foci in rat liver during phenobarbital promotion.
    Schulte-Hermann R; Timmermann-Trosiener I; Barthel G; Bursch W
    Cancer Res; 1990 Aug; 50(16):5127-35. PubMed ID: 2379175
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Some conclusions derived from a liver model for carcinogenesis.
    Cameron R; Farber E
    Natl Cancer Inst Monogr; 1981 Dec; (58):49-53. PubMed ID: 7341983
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sequential alterations in growth control and cell dynamics of rat hepatocytes in early precancerous steps in hepatocarcinogenesis.
    Rotstein J; Sarma DS; Farber E
    Cancer Res; 1986 May; 46(5):2377-85. PubMed ID: 3697980
    [TBL] [Abstract][Full Text] [Related]  

  • 13. NTP Hepatotoxicity Studies of the Liver Carcinogen Methapyrilene Hydrochloride (CAS No. 135-23-9) Administered in Feed to Male F344/N Rats.
    Toxic Rep Ser; 2000 Feb; 46():1-C7. PubMed ID: 11986676
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of hepatocyte proliferation in alpha-hexachlorocyclohexane and phenobarbital tumor promotion in B6C3F1 mice.
    Siglin JC; Weghorst CM; Klaunig JE
    Prog Clin Biol Res; 1991; 369():407-16. PubMed ID: 1719565
    [No Abstract]   [Full Text] [Related]  

  • 15. Active cell death (apoptosis) and cellular proliferation as indicators of exposure to carcinogens.
    Schulte-Hermann R; Bursch W; Marian B; Grasl-Kraupp B
    IARC Sci Publ; 1999; (146):273-85. PubMed ID: 10353391
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inherent increase of apoptosis in liver tumors: implications for carcinogenesis and tumor regression.
    Grasl-Kraupp B; Ruttkay-Nedecky B; Müllauer L; Taper H; Huber W; Bursch W; Schulte-Hermann R
    Hepatology; 1997 Apr; 25(4):906-12. PubMed ID: 9096596
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chloroform mode of action: implications for cancer risk assessment.
    Golden RJ; Holm SE; Robinson DE; Julkunen PH; Reese EA
    Regul Toxicol Pharmacol; 1997 Oct; 26(2):142-55. PubMed ID: 9356278
    [TBL] [Abstract][Full Text] [Related]  

  • 18. NTP Toxicology and Carcinogenesis Studies of C.I. Direct Blue 218 (CAS No. 28407-37-6) in F344/N Rats and B6C3F1 Mice (Feed Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1994 Feb; 430():1-280. PubMed ID: 12616301
    [TBL] [Abstract][Full Text] [Related]  

  • 19. NTP toxicology and carcinogenesis studies of 3,3',4,4',5-pentachlorobiphenyl (PCB 126) (CAS No. 57465-28-8) in female Harlan Sprague-Dawley rats (Gavage Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 2006 Jan; (520):4-246. PubMed ID: 16628245
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A clonal growth model: time-course simulations of liver foci growth following penta- or hexachlorobenzene treatment in a medium-term bioassay.
    Ou YC; Conolly RB; Thomas RS; Xu Y; Andersen ME; Chubb LS; Pitot HC; Yang RS
    Cancer Res; 2001 Mar; 61(5):1879-89. PubMed ID: 11280742
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.